Imexpharm Corp banner
I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 53 600 VND 0.37% Market Closed
Market Cap: ₫8.3T

Wall Street
Price Targets

IMP Price Targets Summary
Imexpharm Corp

Wall Street analysts forecast IMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMP is 54 264 VND with a low forecast of 51 611 VND and a high forecast of 57 750 VND.

Lowest
Price Target
51 611 VND
4% Downside
Average
Price Target
54 264 VND
1% Upside
Highest
Price Target
57 750 VND
8% Upside
Imexpharm Corp Competitors:
Price Targets
UUU
3U Holding AG
97% Upside

Revenue
Forecast

9% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
9% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Imexpharm Corp's revenue is 9%. The projected CAGR for the next 2 years is 16%.

Operating Income
Forecast

11% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
11% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 14 years the compound annual growth rate for Imexpharm Corp's operating income is 11%. The projected CAGR for the next 2 years is 19%.

Net Income
Forecast

10% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
10% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 14 years the compound annual growth rate for Imexpharm Corp's net income is 10%. The projected CAGR for the next 2 years is 22%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMP's stock price target?
Price Target
54 264 VND

According to Wall Street analysts, the average 1-year price target for IMP is 54 264 VND with a low forecast of 51 611 VND and a high forecast of 57 750 VND.

What is Imexpharm Corp's Revenue forecast?
Projected CAGR
16%

For the last 14 years the compound annual growth rate for Imexpharm Corp's revenue is 9%. The projected CAGR for the next 2 years is 16%.

What is Imexpharm Corp's Operating Income forecast?
Projected CAGR
19%

For the last 14 years the compound annual growth rate for Imexpharm Corp's operating income is 11%. The projected CAGR for the next 2 years is 19%.

What is Imexpharm Corp's Net Income forecast?
Projected CAGR
22%

For the last 14 years the compound annual growth rate for Imexpharm Corp's net income is 10%. The projected CAGR for the next 2 years is 22%.

Back to Top